Surgery Partners, Inc. (NASDAQ:SGRY) is highlighted as one of the 12 Stocks that Will Bounce Back, with RBC Capital reiterating a Buy rating and $31 price target on December 19. Mizuho Securities also maintains an Outperform rating despite lowering its price target from $22 to $19 on December 18.

Mizuho Securities predicts 2026 will be a pivotal year for the sector, expecting improved margins across commercial insurance, Medicaid, and Medicare. Despite reducing its price target on SGRY, the firm remains optimistic about managed care in the coming years.

Surgery Partners, Inc. (NASDAQ:SGRY) is a major healthcare services company, boasting over 200 locations in 30 states. While SGRY shows investment potential, some AI stocks offer higher upside with less risk. For those interested in undervalued AI stocks benefiting from current trends, a free report is available.

For more investment options, check out the 10 Best US Penny Stocks to Buy and 10 Best New Penny Stocks to Invest In. This article is originally published on Insider Monkey.

Read more at Yahoo Finance: RBC Capital and Mizuho Securities Stay Bullish on Surgery Partners (SGRY)